Both are prescriptiononly compounds typically compounded by pharmacies
While results from different studies are not comparable linearly, nothing in resmetirom's pivotal trial suggests that it is superior to semaglutide or tirzepatide
Rosiglitazone Rosiglitazone was marketed both alone (Avandia) (National Center for Biotechnology Information, 2023b) and combined with metformin (National Center for Biotechnology Information, 2023e) (Avandamet) or with glimepiride (National Center for Biotechnology Information, 2023d) (Avandaryl)
This clearance mechanism has also been described in the context of different cellular stressors leading to PS exposure, e.g., hyperosmotic stress [217], plasmodium infection [77], oxidative stress [72], and, to some extent, also ageing of erythrocytes [218]